DALLAS–(BUSINESS WIRE)–Arcosa, Inc. (NYSE: ACA) (“Arcosa”) today announced it has closed the previously announced private offering…
Continue ReadingEtiqueta: Business Wire
Botanical Solution Inc. (BSI) Series A Extended to Over $23 Million
Funding to accelerate scalable commercial production of pharmaceutical grade QS-21 for human vaccines, R&D lab expansion,…
Continue ReadingHovde Group Expands Depository Team With Addition of Veteran Investment Banker James F. Hemmer
CHICAGO–(BUSINESS WIRE)–Hovde Group, LLC (“Hovde”), a leading full-service investment bank and broker dealer that provides investment…
Continue Reading
KB Home Announces the Grand Opening of Its Newest Community Within the Desirable Crossroads West Master Plan in Riverbank, California
Enclave at Crossroads West offers personalized, spacious, new homes and family friendly amenities close to local…
Continue Reading
Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for…
Continue Reading
Triple-I Offers Floridians, Southeast U.S. Residents Preparedness Tips for Impacts of Tropical Storm Debby
ST. JOHNS, Fla.–(BUSINESS WIRE)–Residents of Florida and the Southeast should be alert for the potential impacts…
Continue Reading
RIBOMIC Announces Completion of Patient Enrollment in Early Phase II Study of umedaptanib pegol for Achondroplasia and Initiation of Dosing in Cohort 2 of Early Phase II Clinical Study
TOKYO–(BUSINESS WIRE)–RIBOMIC Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, today announced that 13…
Continue Reading
US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
Jemperli approval now includes MMRp/MSS tumors, which represent majority of endometrial cancer cases Jemperli plus chemotherapy…
Continue Reading
Global Healthcare Logistics Focused Insights Report 2024-2029 with Coverage of 40+ Vendors Including Key Players – Cencora, CEVA, FedEx, Kuehne + Nagel, DB Schenker, DHL, & UPS – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Healthcare Logistics Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s…
Continue ReadingPershing Square USA, Ltd. Clarifies Press Reports
NEW YORK–(BUSINESS WIRE)–Pershing Square USA, Ltd. (“PSUS” or the “Company”), today issued the following statement: To…
Continue Reading